ATE412175T1 - Verwendung von kryptischen peptiden zur induktion von immunologischer toleranz - Google Patents
Verwendung von kryptischen peptiden zur induktion von immunologischer toleranzInfo
- Publication number
- ATE412175T1 ATE412175T1 AT05011041T AT05011041T ATE412175T1 AT E412175 T1 ATE412175 T1 AT E412175T1 AT 05011041 T AT05011041 T AT 05011041T AT 05011041 T AT05011041 T AT 05011041T AT E412175 T1 ATE412175 T1 AT E412175T1
- Authority
- AT
- Austria
- Prior art keywords
- immunological tolerance
- induce immunological
- cryptic peptides
- cryptic
- peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000001900 immune effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Insects & Arthropods (AREA)
- Mycology (AREA)
- Botany (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9605904.3A GB9605904D0 (en) | 1996-03-21 | 1996-03-21 | Peptides |
| GBGB9608430.6A GB9608430D0 (en) | 1996-04-24 | 1996-04-24 | Peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412175T1 true ATE412175T1 (de) | 2008-11-15 |
Family
ID=26308965
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97908389T ATE296444T1 (de) | 1996-03-21 | 1997-03-20 | Kryptische peptide und verfahren zu ihrer identifizierung |
| AT05011041T ATE412175T1 (de) | 1996-03-21 | 1997-03-20 | Verwendung von kryptischen peptiden zur induktion von immunologischer toleranz |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97908389T ATE296444T1 (de) | 1996-03-21 | 1997-03-20 | Kryptische peptide und verfahren zu ihrer identifizierung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6737406B1 (de) |
| EP (2) | EP1612555B1 (de) |
| JP (1) | JP4340329B2 (de) |
| AT (2) | ATE296444T1 (de) |
| AU (1) | AU730198C (de) |
| CA (1) | CA2247009C (de) |
| DE (2) | DE69733343D1 (de) |
| DK (1) | DK1612555T3 (de) |
| ES (1) | ES2314515T3 (de) |
| GB (3) | GB2326642B (de) |
| WO (1) | WO1997035193A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2812087B1 (fr) | 2000-07-21 | 2007-05-11 | Inst Nat Sante Rech Med | Procede de criblage de peptides utilisables en immunotherapie |
| WO2002066979A1 (en) * | 2001-02-22 | 2002-08-29 | Takara Bio Inc. | Method of detecting antigen causative of bronchial asthma |
| RU2334235C2 (ru) * | 2002-06-11 | 2008-09-20 | Мерк Патент Гмбх | Способ картирования и устранения эпитопов т-клеток |
| GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
| MX2010001779A (es) * | 2007-08-15 | 2010-07-06 | Circassia Ltd | Peptidos para vacunas. |
| WO2025194374A1 (zh) * | 2024-03-20 | 2025-09-25 | 深圳赫兹生命科学技术有限公司 | 猫过敏原多肽片段及应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR880701108A (ko) | 1986-06-30 | 1988-07-25 | 원본미기재 | 면역조절 조성물 및 이들의 용도 |
| US5019384A (en) | 1986-06-30 | 1991-05-28 | Massachusetts Institute Of Technology | Immunonodulating compositions and their use |
| US6180368B1 (en) | 1988-03-23 | 2001-01-30 | University Of Melbourne | Ryegrass pollen allergen |
| EP0463059B1 (de) | 1989-03-17 | 1998-12-30 | Immulogic Pharmaceutical Corporation | Allergene proteine aus ambrosia und verwendung davon |
| US5328991A (en) | 1989-11-03 | 1994-07-12 | Immulogic Pharmaceutical Corp. | Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes |
| US5547669A (en) | 1989-11-03 | 1996-08-20 | Immulogic Pharma Corp | Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I |
| AU650249B2 (en) | 1989-11-03 | 1994-06-16 | Immulogic Pharmaceutical Corporation | A human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| US6019972A (en) | 1989-11-03 | 2000-02-01 | Immulogic Pharmaceutical Corporation | Peptides of human T cell reactive feline protein (TRFP) |
| US5433948A (en) | 1990-02-13 | 1995-07-18 | Thomas; Wayne R. | Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| ATE178940T1 (de) | 1990-09-11 | 1999-04-15 | Inst Child Health Research | Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben) |
| JPH06506056A (ja) | 1990-10-30 | 1994-07-07 | イミュロジック ファーマシューティカル コーポレイション | Ｍｈｃ抗原によるペプチド結合検定法 |
| WO1992011859A1 (en) | 1991-01-08 | 1992-07-23 | Immulogic Pharmaceutical Corporation | Peptide-mediated hyposensitization of the human t cell response to dermatophagoides spp. (house dust mite) |
| WO1994001560A1 (en) | 1991-07-12 | 1994-01-20 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from japanese cedar pollen |
| CA2112913A1 (en) | 1991-07-12 | 1993-01-21 | Irwin J. Griffith | Allergenic proteins and peptides from japanese cedar pollen |
| NZ244782A (en) * | 1991-10-16 | 1996-12-20 | Immulogic Pharma Corp | Isolated peptides having t-cell stimulating activity, pharmaceutical composition |
| ATE444360T1 (de) | 1991-10-16 | 2009-10-15 | Merck Patent Gmbh | T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe) |
| WO1994024281A1 (en) | 1993-04-14 | 1994-10-27 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| IL105153A (en) | 1992-03-25 | 1999-12-22 | Immulogic Pharma Corp | Therapeutic compositions comprising peptides derived from human t cell reactive feline protein |
| EP0770681A3 (de) | 1992-04-09 | 1997-06-04 | Immulogic Pharmaceutical Corporation | T-Zellen Epitopen der Hauptallergenen von Ambrosia artemisiifolia |
| AU4796393A (en) | 1992-07-31 | 1994-03-03 | Immulogic Pharmaceutical Corporation | Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen |
| WO1994011512A2 (en) | 1992-11-12 | 1994-05-26 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from japanese cedar pollen |
| ATE318902T1 (de) | 1992-12-31 | 2006-03-15 | Immulogic Pharma Corp | Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung |
| WO1994021675A2 (en) | 1993-03-12 | 1994-09-29 | Immulogic Pharmaceutical Corporation | T cell epitopes of ryegrass pollen allergen |
| NZ266739A (en) | 1993-06-02 | 1997-07-27 | Tvw Telethon Inst Child Health | Inducing immunologic tolerance by administering a cryptic peptide derived from the antigen der pi |
| WO1995001597A2 (en) | 1993-07-01 | 1995-01-12 | British Telecomm | System for generating instructions for speech application |
| FI960629L (fi) | 1993-08-13 | 1996-04-12 | Immulogic Pharma Corp | Raiheinäsiitepöly allergeenin T-soluepitoopit |
| AU2238395A (en) | 1994-04-01 | 1995-10-23 | Immulogic Pharmaceutical Corporation | Haptenated peptides and uses thereof |
| ES2285703T3 (es) | 1994-04-14 | 2007-11-16 | Merck Patent Gmbh | Formulaciones farmaceuticas de peptidos para el tratamiento de alergia a los acaros del polvo. |
| JPH10505356A (ja) * | 1994-09-02 | 1998-05-26 | イミユロジク・フアーマシユーチカル・コーポレーシヨン | ヒトへの投与のための組成物および方法、抗原特異的免疫応答のダウンレギュレーションを行うことが可能なペプチド |
| CZ122697A3 (en) | 1994-10-25 | 1997-09-17 | Immulogic Pharma Corp | Preparations and methods of treating disseminated sclerosis |
| AU4146796A (en) | 1994-10-27 | 1996-05-23 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from ambrosia artemisiifolia |
| WO1996020950A2 (en) | 1995-01-06 | 1996-07-11 | Immulogic Pharmaceutical Corporation | Compositions and methods for treating rheumatoid arthritis |
| US6719976B1 (en) | 1996-03-10 | 2004-04-13 | Meiji Milk Products Co., Ltd. | Peptide-based immunotherapeutic agent for treating allergic diseases |
| US5804201A (en) | 1996-03-11 | 1998-09-08 | The Rockefeller University | Immunomodulatory peptides of vespid antigen 5 |
-
1997
- 1997-03-20 ES ES05011041T patent/ES2314515T3/es not_active Expired - Lifetime
- 1997-03-20 CA CA002247009A patent/CA2247009C/en not_active Expired - Lifetime
- 1997-03-20 WO PCT/GB1997/000783 patent/WO1997035193A1/en not_active Ceased
- 1997-03-20 DE DE69733343T patent/DE69733343D1/de not_active Expired - Lifetime
- 1997-03-20 US US09/142,885 patent/US6737406B1/en not_active Expired - Lifetime
- 1997-03-20 DE DE69739062T patent/DE69739062D1/de not_active Expired - Lifetime
- 1997-03-20 AT AT97908389T patent/ATE296444T1/de not_active IP Right Cessation
- 1997-03-20 GB GB9817461A patent/GB2326642B/en not_active Expired - Lifetime
- 1997-03-20 EP EP05011041A patent/EP1612555B1/de not_active Expired - Lifetime
- 1997-03-20 GB GB0027373A patent/GB2352518B/en not_active Expired - Fee Related
- 1997-03-20 DK DK05011041T patent/DK1612555T3/da active
- 1997-03-20 GB GB0020260A patent/GB2349463B/en not_active Expired - Fee Related
- 1997-03-20 EP EP97908389A patent/EP0888541B1/de not_active Expired - Lifetime
- 1997-03-20 AU AU20365/97A patent/AU730198C/en not_active Expired
- 1997-03-20 AT AT05011041T patent/ATE412175T1/de active
- 1997-03-20 JP JP53327097A patent/JP4340329B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69733343D1 (de) | 2005-06-30 |
| GB2349463A (en) | 2000-11-01 |
| CA2247009C (en) | 2009-08-04 |
| JP2000508627A (ja) | 2000-07-11 |
| GB2352518A (en) | 2001-01-31 |
| DE69739062D1 (de) | 2008-12-04 |
| EP0888541B1 (de) | 2005-05-25 |
| GB2352518B (en) | 2001-04-04 |
| GB0027373D0 (en) | 2000-12-27 |
| EP0888541A1 (de) | 1999-01-07 |
| GB2349463B (en) | 2001-01-10 |
| WO1997035193A1 (en) | 1997-09-25 |
| ATE296444T1 (de) | 2005-06-15 |
| AU730198C (en) | 2002-03-14 |
| AU730198B2 (en) | 2001-03-01 |
| JP4340329B2 (ja) | 2009-10-07 |
| GB0020260D0 (en) | 2000-10-04 |
| CA2247009A1 (en) | 1997-09-25 |
| EP1612555B1 (de) | 2008-10-22 |
| GB9817461D0 (en) | 1998-10-07 |
| EP1612555A1 (de) | 2006-01-04 |
| AU2036597A (en) | 1997-10-10 |
| GB2326642A (en) | 1998-12-30 |
| ES2314515T3 (es) | 2009-03-16 |
| US6737406B1 (en) | 2004-05-18 |
| GB2326642B (en) | 2001-02-07 |
| DK1612555T3 (da) | 2009-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9501276D0 (en) | Stabile, liophylised composition containing proteins | |
| DE4393381T1 (de) | Peptide | |
| ATE76309T1 (de) | Dialyseloesung und ihre herstellung unter verwendung von peptiden auf der basis von glycin. | |
| FI954559A0 (fi) | YY-peptidin analogit ja niiden käytöt | |
| ES2120964T3 (es) | Peptidos osteogenicos. | |
| DE69526801D1 (de) | Aerosolformulierungen mit peptiden und proteinen | |
| DK6893D0 (da) | Peptid | |
| DE69333921D1 (de) | "enhancer" sequenz zur modulation der expression in epithelialzellen | |
| GR3004556T3 (de) | ||
| DE69739062D1 (de) | Verwendung von kryptischen Peptiden zur Induktion von immunologischer Toleranz | |
| FI961634A7 (fi) | Antitromboottisia atsasykloalkyylialkanoyyli peptidejä ja pseudopeptid ejä | |
| DE69427363D1 (de) | Plättchenaggregationsinhibierende peptide | |
| KR900011856A (ko) | 혼성 아미노 수지 조성물 | |
| FI943218L (fi) | Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt | |
| ZA946887B (en) | Novel proteins/polypeptides and cotransfection plasmics and live recombinant carriers therefor | |
| DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
| FI885301A7 (fi) | Tekijä VIII:n puhdistuksessa käyttökelpoisia peptidejä | |
| KR900011857A (ko) | 혼성 아미노 수지 조성물 | |
| DE69613086D1 (de) | Antigenen Peptide mit Glycinsubstitution | |
| NO177858C (no) | Peptid | |
| KR900011855A (ko) | 혼성 아미노 수지 조성물 | |
| DE69420044D1 (de) | Blutregulierende peptide | |
| IT9019021A0 (it) | Composizioni a base di prolina,glicina e lisina per il trattamento della carenza di collagene | |
| DE69635457D1 (de) | Deprenyl induziertes protein | |
| DE69030316D1 (de) | Schrittweiser c-terminaler abbau von peptiden und proteinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1612555 Country of ref document: EP |